About Optimi
Supplying natural, EU-GMP psilocybin and synthetic psychedelics for a world in need NASDAQ: OPTH
- Industry
- Wellness and Fitness Services
- Company size
- 11-50 employees
- Headquarters
- Princeton, British Columbia
- Founded
- 2020
- Company type
- Public Company
Optimi Health Corp. (Nasdaq: OPTH) is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. As a Health Canada-licensed pharmaceutical manufacturer, Optimi produces validated MDMA and botanical psilocybin drug products at its GMP-compliant facilities in British Columbia, Canada.
Optimi supplies both active pharmaceutical ingredients and finished dosage forms to regulated clinical and therapeutic programs internationally, with products currently prescribed to patients in Australia under the country’s Authorized Prescriber Scheme and accessible in Canada through the Special Access Program.
Company locations
Princeton, British Columbia, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
On LinkedIn
- Followers
- 2,280
- People linked to this company
- 21
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.